Join Us for A FOCUSED FUTURE
The 5th International Conference on DADA2 is SPRING 2026, in Bethesda, Maryland - just outside Washington, DC, and very close to the National Institutes of Health (NIH)!
LOCATION: TBD
8:00 a.m. - 6:00 p.m. (Eastern Standard Time in the U.S.)
Reception to follow
This year, our theme is A Focused Future. By invite only, we are gathering a smaller group of the most active DADA2 researchers and clinicians. Our goal is to look ahead with precision and purpose during this concentrated gathering so that we can bring both clarity to outstanding questions and explore the possibilities in potential treatments and cures.
We look forward to reporting out on our findings, further questions, and recommendations for future scientific research and clinical ideas.
Our Focused Agenda
We look forward to gathering as a focused group to:
- Explore detailed advancements in both genetic therapy and enzyme replacement therapy. In particular, we will explore the DADA2 Foundation’s acquisition of Pegylated ADA2 Enzyme as a possible future therapy for patients.
- Begin the most essential design of the DADA2 Patient Registry and Natural History Study, and determine a path to manage and analyze the data once collected.
- Advance collective knowledge and tackle key research questions raised in the literature in the last two years, and reconcile them to the foundational research.
- Emerge with a more focused research pathway for the international DADA2 community.